Events & Presentations

Investors

Events & Presentations

Upcoming Events
Date Event Details Remind Me
Nov 18, 2019
American Heart Association Scientific Sessions 2019

November 18, 9:32 a.m. EST – Dr. Christie Ballantyne, Baylor Coll Med, Houston, TX, will deliver an oral presentation titled, “RNA Interference Targeting Apolipoprotein C-III Results in Deep and Prolonged Reductions in Plasma Triglycerides”

November 18, 9:38 a.m. EST – Dr. Gerald Watts, Univ of Western Australia, Royal Perth Hosp, Perth, Australia, will deliver an oral presentation titled, “RNA Interference Targeting Hepatic Angiopoietin-Like Protein 3 Results in Prolonged Reductions in Plasma Triglycerides and LDL-C in Human Subjects”

Philadelphia
Nov 25, 2019 4:30 PM EST
Arrowhead Pharmaceuticals 2019 Year End Results
Archived Events
Date Event Details
Sep 5, 2019
Citi’s 14th Annual Biotech Conference
Boston, MA
Sep 4, 2019 9:40 AM EDT
Baird's 2019 Global Healthcare Conference
New York, NY
Aug 12, 2019
BTIG Biotechnology Conference 2019
New York, NY
Aug 5, 2019 4:30 PM EDT
Arrowhead Pharmaceuticals 2019 Third Quarter Results
Jul 17, 2019
Roth RNA Revolution Conference
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, and Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in panel discussions.
Jun 21, 2019
Alpha-1 National Conference
Orlando, FL
James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “ARO-AAT for Liver Disease in Alpha-1 Antitrypsin Deficiency: Progress in Clinical Development”
Jun 8, 2019 2:30 PM +08
Science of HBV Cure 2019
Singapore
Bruce Give, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver an oral presentation titled, “RNAi: Pulling Us Toward Finite Therapy”
Jun 6, 2019 9:30 AM EDT
Jefferies 2019 Global Health Care Conference
New York, NY
Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in a fireside chat presentation with Maury Raycroft, Ph.D., Jefferies research analyst
May 23, 2019 8:30 AM PDT
20ᵀᴴ Annual B. Riley FBR Institutional Investor Conference
Beverly Hills
Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will participate in a fireside chat presentation with Mayank Mamtani, B. Riley FBR research analyst
May 18, 2019 11:25 AM EDT
2019 National Lipid Association Scientific Sessions
Aventura, FL

So Wong, Ph.D., Arrowhead’s director of biology, will deliver a poster presentation titled, “Personalized Medicine for Dyslipidemias by RNA Interference-Mediated Reductions in Apolipoprotein C3 or Angiopoietin-Like Protein 3”